Key facts
- This page summarizes Uri Ben-Or's Form 3 filing for Nuvectis Pharma, Inc. (NVCT).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Feb 2022, 08:24.
Uri Ben-Or - 08 Feb 2022 Form 3 Insider Report for Nuvectis Pharma, Inc. (NVCT)
- Reporting relationship
- Int. Principal Financial Off.
- Issuer ticker
- NVCT
- Reported as of
- 08 Feb 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 08 Feb 2022, 08:24:29 UTC
- Next SEC filing
- 03 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Uri Ben-Or
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Uri Ben-Or filed Form 3 for Nuvectis Pharma, Inc. (NVCT) on 08 Feb 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NVCT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 25,584
- Date
- 08 Feb 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.